Physician profile
Rachel Bray
NPI 1881695369
$1,842.40
in general payments reported to CMS, 2019-2025
19 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $111 · 2021: $234 · 2022: $283 · 2023: $333 · 2024: $357 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $611.60 | 2021-2025 | Azstarys |
| Sobi, INC | $329.36 | 2019-2023 | |
| Cranial Technologies, INC | $258.05 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $107.11 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $84.25 | 2025 | Jornay Pm |
| Tris Pharma INC | $65.90 | 2019 | |
| Pfizer INC. | $61.54 | 2019-2023 | |
| Ucb, INC. | $60.34 | 2024 | Nayzilam |
| Shire North American Group INC | $42.31 | 2019 | |
| Merck Sharp & Dohme LLC | $38.74 | 2019-2023 | M-M-R II, Vaqta, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $32.96 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $23.17 | 2023 | |
| Phadia US INC. | $21.46 | 2024 | Immunocap |
| Acadia Pharmaceuticals INC | $20.88 | 2025 | Daybue |
| Sanofi-Aventis U.S. LLC | $18.99 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $18.48 | 2025 | |
| Kaleo, INC. | $17.28 | 2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $16.23 | 2020 | |
| Azurity Pharmaceuticals, INC. | $13.75 | 2025 | Alvesco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Bray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.